Skip to main content
. 2024 Dec 12;15:1507371. doi: 10.3389/fimmu.2024.1507371

Figure 4.

Figure 4

Relapse-free survival rates according to PT-TLS abundance in the whole cohort (A), and in patients treated (B) or not (C) with adjuvant chemotherapy (CT).